Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Nitric Oxide Production and Nitric Oxide Synthase Type 2 Expression by Human Mononuclear Phagocytes: A Review

Fig. 3

NOS enzyme activity in extracts of blood mononuclear cells (A), serum alanine aminotransferase (ALT) (B), plasma hepatitis C RNA levels (C), and NOS enzyme activity before and after IFN-α treatment (D). The bars show the mean + 1 SEM for samples taken from the different subject groups. Control, normal control subjects; Hep C, patients with hepatitis C not on therapy; Hep C + IFN, patients with hepatitis C on IFN-α therapy. For NOS measurements, n = 9 for control, 18 for Hep C, and 15 for Hep C + IFN; for serum ALT, n = 15; and for plasma hepatitis C RNA, n = 4. In D, the lines connect the values from an individual patient’s samples pre-IFN-α and post-IFN-α therapy. The solid squares show the means and 1 SEM of the groups. [Reproduced with permission (76).]

Back to article page